Please login to the form below

Not currently logged in
Email:
Password:

financial results 2012

This page shows the latest financial results 2012 news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs OTC use of Sanofi's allergy drug

FDA panel backs OTC use of Sanofi's allergy drug

Profits have declined since 2008, however, when Teva and Barr Pharmaceuticals won a patient challenge to launch their own generic copy, and Nasacort AQ achieved revenues of just 71m during 2012 ... This is part of a wider plan to build its consumer

Latest news

More from news
Approximately 17 fully matching, plus 18 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics